← Signals
Signal

Genentech: Personalized Medicine Is Moving From Possibility To Platform

At Genentech, a member of the Roche Group, I addressed 550 executives in San Francisco and challenged them to think beyond breakthrough science toward the broader reinvention made possible by exponential genomics.

signal2025-2026keynote-case-study
Publish Date2026-09-16
Updated Date2026-09-18
Observed Date2026-09-16
Strengthstrong

Observed in Jim Carroll’s archive on September 16, 2026.

At Genentech, a member of the Roche Group, I addressed 550 executives in San Francisco and challenged them to think beyond breakthrough science toward the broader reinvention made possible by exponential genomics.

Source: Keynote Case Study: Genentech: Personalized Medicine Is Moving From Possibility To Platform..

Connected knowledge

Trends

Connected knowledge

Industries

Connected knowledge

Domains

Connected knowledge

Sources

CONNECTED KNOWLEDGE

Go deeper

From Jim's archive

These are the source records currently attached directly to this knowledge object. Concept-lineage and collection pages can provide a wider historical trail.